文献速递急性肾损伤慢性肾脏病

衰老肾脏与急性肾损伤

The Aging Kidney and Acute Kidney Injury.
PubMed 文献 · J Am Soc Nephrol · 2025-12-16

本文综述衰老与急性肾损伤(AKI)的关系。衰老细胞通过衰老相关分泌表型(SASP)扩散衰老效应, predispose 慢性肾脏病(CKD)和 AKI。年龄增加人类 AKI 风险,综述讨论衰老细胞在 AKI 发病中的作用、肾外环境及 distant 器官的影响、血红素作为促衰老因子、衰老在 AKI 向 CKD 转化中的作用,以及 senolytics、senomorphics 等抗衰老治疗的基础。

要点

  • 衰老增加人类 AKI 风险,与肾脏衰老过程中多种 AKI 相关过程有关。
  • 衰老细胞通过 SASP 扩散衰老效应,促进炎症、纤维化等。
  • 抗衰老治疗包括 senolytics 和 senomorphics,可能针对衰老细胞。

核心结论

  • 衰老通过多种机制增加 AKI 风险,衰老细胞及其分泌表型发挥重要作用。
  • 抗衰老治疗可能为 AKI 防治提供新方向。

研究设计与样本

  • 综述,未报告系统检索范围。

主要发现

  • 衰老细胞具有细胞周期停滞、抗凋亡、β-半乳糖苷酶活性增加和 SASP 表达。
  • SASP 产生炎症、细胞毒性、纤维化和血管活性因子,可扩散至邻近和远处细胞。
  • 衰老 predispose 慢性疾病(包括 CKD)和急性过程(包括 AKI)。
  • 年龄增加人类 AKI 风险,涉及衰老细胞、血管反应、糖尿病、NAD+ 含量受损、sirtuin 表达、线粒体功能障碍、自噬受损、表观遗传改变、端粒缩短、肾保护因子表达受损、炎症衰老和免疫衰老等过程。
  • 血红素是促衰老物种,衰老参与 AKI 向 CKD 转化。

临床怎么用

  • 临床应关注老年患者 AKI 风险,考虑衰老相关机制。
  • senolytics 和 senomorphics 等抗衰老治疗可能未来用于 AKI 防治。

局限性

  • 本文为综述,未报告系统检索策略和证据等级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Aging is unavoidable and driven, at least in part, by the biologic process termed senescence. Senescence is characterized by cell cycle arrest incurred by one or more stressors wherein there is cellular upregulation of cyclin-dependent kinase inhibitors, p16 Ink4a and/or p21 Cip1 . Senescent cells are metabolically active and resistant to apoptosis, have increased β -galactosidase activity, and express a senescence-associated secretory phenotype (SASP). The SASP produces an array of inflammatory, cytotoxic, fibrotic, and vasoactive factors. Senescence is a diffusible process as, largely through the SASP, a focus of senescent cells can recruit adjacent cells and cells in distant organs, thereby expanding its scope way beyond its original focus. Senescence predisposes not only to chronic diseases (including CKD) but also acute processes (including AKI). This review provides evidence that age increases the risk of human AKI and summarizes clinical factors that predispose older individuals to AKI. It provides an overview of the biology of senescence, and it discusses the role of intrarenal senescent cells in the pathogenesis of AKI, the significance of the extrarenal milieu and distant organs in predisposing to AKI with age, heme as a prosenescent species, and the role of senescence in the AKI to CKD transition. The risk for AKI with aging, in large part, reflects the fact that virtually all processes implicated in AKI, irrespective of age, occur as the kidney ages. Processes discussed include senescent cells, vascular responses, diabetes, impaired NAD + content, sirtuin expression, mitochondrial dysfunction, impaired autophagy, epigenetic changes, telomere shortening, impaired nephroprotectant expression, inflammaging, and immunosenescence. The review concludes by discussing the basis for senolytics (agents that kill senescent cells), senomorphics (agents that block SASP factors), and other aspects of senotherapies.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Nath KA, Singh RD, Croatt AJ, et al. The Aging Kidney and Acute Kidney Injury. J Am Soc Nephrol. 2025. PMID: 41563815. doi:10.1681/ASN.0000001002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。